270 related articles for article (PubMed ID: 30717056)
1. Moyamoya syndrome and PHACE syndrome: clinical and radiographic characterization of the intracranial arteriopathy and response to surgical revascularization.
Jernigan S; Storey A; Hammer C; Riordan C; Orbach DB; Scott RM; Smith E
J Neurosurg Pediatr; 2019 Feb; 23(4):493-497. PubMed ID: 30717056
[TBL] [Abstract][Full Text] [Related]
2. Bilateral pial synangiosis in a child with PHACE syndrome.
Jack AS; Chow MM; Fiorillo L; Chibuk T; Yager JY; Mehta V
J Neurosurg Pediatr; 2016 Jan; 17(1):70-5. PubMed ID: 26405843
[TBL] [Abstract][Full Text] [Related]
3. Moyamoya Vasculopathy in PHACE Syndrome: Six New Cases and Review of the Literature.
Tortora D; Severino M; Accogli A; Martinetti C; Vercellino N; Capra V; Rossi A; Pavanello M
World Neurosurg; 2017 Dec; 108():291-302. PubMed ID: 28887276
[TBL] [Abstract][Full Text] [Related]
4. Treatment of Moyamoya disease in the adult population with pial synangiosis.
Lin N; Aronson JP; Manjila S; Smith ER; Scott RM
J Neurosurg; 2014 Mar; 120(3):612-7. PubMed ID: 24405066
[TBL] [Abstract][Full Text] [Related]
5. Pial synangiosis in patients with moyamoya syndrome and sickle cell anemia: perioperative management and surgical outcome.
Smith ER; McClain CD; Heeney M; Scott RM
Neurosurg Focus; 2009 Apr; 26(4):E10. PubMed ID: 19335126
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis.
Scott RM; Smith JL; Robertson RL; Madsen JR; Soriano SG; Rockoff MA
J Neurosurg; 2004 Feb; 100(2 Suppl Pediatrics):142-9. PubMed ID: 14758941
[TBL] [Abstract][Full Text] [Related]
7. Moyamoya syndrome associated with Down syndrome: outcome after surgical revascularization.
Jea A; Smith ER; Robertson R; Scott RM
Pediatrics; 2005 Nov; 116(5):e694-701. PubMed ID: 16263984
[TBL] [Abstract][Full Text] [Related]
8. Surgical Revascularization for Children with Moyamoya Disease: A New Modification to the Pial Synangiosis.
Chen C; Wang H; Hou B; Luo L; Guo Y
World Neurosurg; 2018 Feb; 110():e203-e211. PubMed ID: 29102749
[TBL] [Abstract][Full Text] [Related]
9. Moyamoya syndrome associated with neurofibromatosis Type 1: perioperative and long-term outcome after surgical revascularization.
Koss M; Scott RM; Irons MB; Smith ER; Ullrich NJ
J Neurosurg Pediatr; 2013 Apr; 11(4):417-25. PubMed ID: 23373626
[TBL] [Abstract][Full Text] [Related]
10. Management of PHACES syndrome: Risk of stroke and its prevention from a neurosurgical perspective.
Habib M; Manilha R; Khan N
Eur J Paediatr Neurol; 2020 May; 26():39-45. PubMed ID: 32276757
[TBL] [Abstract][Full Text] [Related]
11. Pial synangiosis in patients with moyamoya younger than 2 years of age.
Jackson EM; Lin N; Manjila S; Scott RM; Smith ER
J Neurosurg Pediatr; 2014 Apr; 13(4):420-5. PubMed ID: 24527861
[TBL] [Abstract][Full Text] [Related]
12. Posterior cerebral territory ischemia in pediatric moyamoya: Surgical techniques and long-term clinical and radiographic outcomes.
Montaser A; Kappel AD; Driscoll J; Day E; Karsten M; See AP; Orbach DB; Smith ER
Childs Nerv Syst; 2024 Mar; 40(3):791-800. PubMed ID: 37955716
[TBL] [Abstract][Full Text] [Related]
13. Down syndrome and moyamoya: clinical presentation and surgical management.
See AP; Ropper AE; Underberg DL; Robertson RL; Scott RM; Smith ER
J Neurosurg Pediatr; 2015 Jul; 16(1):58-63. PubMed ID: 25837890
[TBL] [Abstract][Full Text] [Related]
14. Preoperative transdural collateral vessels in moyamoya as radiographic biomarkers of disease.
Storey A; Michael Scott R; Robertson R; Smith E
J Neurosurg Pediatr; 2017 Mar; 19(3):289-295. PubMed ID: 27935469
[TBL] [Abstract][Full Text] [Related]
15. Progression of disease in unilateral moyamoya syndrome.
Smith ER; Scott RM
Neurosurg Focus; 2008; 24(2):E17. PubMed ID: 18275294
[TBL] [Abstract][Full Text] [Related]
16. Relative contributions of the middle meningeal artery and superficial temporal artery in revascularization surgery for moyamoya syndrome in children: the results of superselective angiography.
King JA; Armstrong D; Vachhrajani S; Dirks PB
J Neurosurg Pediatr; 2010 Feb; 5(2):184-9. PubMed ID: 20121368
[TBL] [Abstract][Full Text] [Related]
17. Moyamoya angiopathy in PHACE syndrome not associated with RNF213 variants.
Hadisurya J; Guey S; Grangeon L; Wieczorek D; Corpechot M; Schwitalla JC; Kraemer M
Childs Nerv Syst; 2019 Jul; 35(7):1231-1237. PubMed ID: 31037424
[TBL] [Abstract][Full Text] [Related]
18. [Pial synangiosis for moyamoya disease. The Bordeaux experience].
Jecko V; Penchet G; Champeaux C
Neurochirurgie; 2016 Aug; 62(4):190-6. PubMed ID: 27113323
[TBL] [Abstract][Full Text] [Related]
19. Indirect revascularization with the dural inversion technique for pediatric moyamoya disease: 20-year experience.
Gadgil N; Lam S; Pyarali M; Paldino M; Pan IW; Dauser RC
J Neurosurg Pediatr; 2018 Nov; 22(5):541-549. PubMed ID: 30117790
[TBL] [Abstract][Full Text] [Related]
20. Surgical treatment of moyamoya syndrome in patients with sickle cell anemia: outcome following encephaloduroarteriosynangiosis.
Hankinson TC; Bohman LE; Heyer G; Licursi M; Ghatan S; Feldstein NA; Anderson RC
J Neurosurg Pediatr; 2008 Mar; 1(3):211-6. PubMed ID: 18352765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
